Literature DB >> 15860137

Massive cerebral infarction.

Suresh Subramaniam1, Michael D Hill.   

Abstract

BACKGROUND: Massive cerebral infarcts cause brain edema with midline shifts and impingement on vital structures producing coma and death. The mortality rate is estimated at 80% with standard medical treatment. Surgical decompression with hemicraniectomy has proved to be life saving, but the impact on functional outcomes is largely unknown. The focus of this review is to discuss the treatment options for massive cerebral infarcts. REVIEW
SUMMARY: Neurologic deterioration following massive cerebral infarct needs to be recognized early enough for medical and surgical interventions. Medical management includes monitoring in a neurologic intensive care unit, hyperosmolar agents, and hyperventilation. Surgical management includes decompressive hemicraniectomy and duraplasty with resection of infarcted tissue in some instances.
CONCLUSION: Hemicraniectomy is emerging as a promising treatment of patients with massive cerebral infarcts, but only select patients benefit from this procedure. Further information from randomized controlled trials is required to elucidate the best treatment options for this kind of stroke.

Entities:  

Mesh:

Year:  2005        PMID: 15860137     DOI: 10.1097/01.nrl.0000159987.70461.d7

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  7 in total

1.  SAM, a cystathionine beta-synthase activator, promotes hydrogen sulfide to promote neural repair resulting from massive cerebral infarction induced by middle cerebral artery occlusion.

Authors:  Fang Wang; Hao Zhou; Xiaoxia Zhang
Journal:  Metab Brain Dis       Date:  2022-04-07       Impact factor: 3.584

2.  Mesenchymal Stem Cell-Derived Exosomes Improved Cerebral Infarction via Transferring miR-23a-3p to Activate Microglia.

Authors:  Chenglong Dong; Maogang Chen; Binggang Cai; Cheng Zhang; Guodong Xiao; Weifeng Luo
Journal:  Neuromolecular Med       Date:  2022-01-10       Impact factor: 4.103

3.  Long-term survival in permanent middle cerebral artery occlusion: a model of malignant stroke in rats.

Authors:  Nagesh C Shanbhag; Robert H Henning; Lothar Schilling
Journal:  Sci Rep       Date:  2016-06-22       Impact factor: 4.379

4.  Age-specific clinical characteristics and outcome in patients over 60 years old with large hemispheric infarction.

Authors:  Jie Li; Ping Zhang; Wendan Tao; Xingyang Yi; Jing Zhang; Chun Wang
Journal:  Brain Behav       Date:  2018-11-22       Impact factor: 2.708

5.  Implant for Augmentation of Cerebral Blood Flow Trial-1 (ImpACT-1). A single-arm feasibility study evaluating the safety and potential benefit of the Ischemic Stroke System for treatment of acute ischemic stroke.

Authors:  Dheeraj Khurana; Subhash Kaul; Dietmar Schneider; Attila Csanyi; Ilona Adam; Nasli R Ichaporia; Bernd Griewing; Laszlo Csiba; Attila Valikovics; Vinod Puri; Hans Christoph Diener; Stefan Schwab; Andreas Hetzel; Natan Bornstein
Journal:  PLoS One       Date:  2019-07-03       Impact factor: 3.240

6.  The Value of a Management Plan Based on Risk Factors for Cerebral Infarction Patients with Cerebral Hemorrhage.

Authors:  Jinfeng Dang; Jieting Li; Haixia Li; Gaoyan Pian; Zhizhuan Guo
Journal:  J Healthc Eng       Date:  2022-04-08       Impact factor: 3.822

7.  Analysis of treatment effect of urinary kallidinogenase combined with edaravone on massive cerebral infarction.

Authors:  Jiang Ke; Mou Jing
Journal:  Biomed Rep       Date:  2016-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.